GlassScriptPhysician profile
Richard J Beira
NPI 1588692552
$5,807.98
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $1,532 · 2021: $3,022 · 2022: $355.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $841.43 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $674.33 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $507.51 | 2019-2021 | |
| Gilead Sciences, INC. | $367.02 | 2021 | |
| Novo Nordisk INC | $350.15 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $319.60 | 2019-2021 | |
| Allergan, INC. | $305.00 | 2019-2020 | |
| Glaxosmithkline, LLC. | $296.74 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $257.41 | 2020-2022 | |
| Lilly USA, LLC | $202.37 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.98 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $159.87 | 2020-2022 | |
| Redhill Biopharma INC. | $153.25 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $140.04 | 2019-2022 | |
| Amarin Pharma, INC. | $133.58 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $117.22 | 2021 | |
| Amgen INC. | $109.84 | 2021 | |
| Novartis Pharmaceuticals Corporation | $106.32 | 2020-2022 | |
| Astellas Pharma US INC | $98.36 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $62.83 | 2020-2021 | |
| Pfizer INC. | $62.40 | 2019-2021 | |
| Horizon Therapeutics Plc | $56.52 | 2019-2021 | |
| Esperion Therapeutics, INC. | $53.44 | 2020-2021 | |
| Viiv Healthcare Company | $40.20 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $39.95 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $36.50 | 2021 | |
| Abbott Laboratories | $31.95 | 2021-2022 | |
| Leo Pharma INC. | $27.61 | 2021 | |
| Biodelivery Sciences International, INC. | $16.99 | 2020 | |
| Ucb, INC. | $16.61 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $15.69 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $11.63 | 2021 | |
| Scilex Pharmaceuticals INC. | $11.06 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Beira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.